Data Breach Roundup (June 12 - 18, 2026)

Novo Nordisk is a Danish pharmaceutical company, best known as the maker of the recent GLP-1 receptor agonist drugs Wegovy and Ozempic. At this time we don't know when the breach occurred or how many people were impacted, but we do know it impacted data related to patients in certain clinical trials including patient IDs (random alphanumeric strings) and information on trial participation, sex, year of birth, biomarkers, health/immunogenicity data, and lifestyle factors (e.g., smoking, alcohol use, BMI). It also affected healthcare professionals (HCPs), whose names, registration numbers, e-mail addresses, phone numbers, WhatsApp details, and office locations have been exposed. The group is asking for a $25 million ransom.

This is a companion discussion topic for the original entry at https://www.privacyguides.org/news/2026/06/19/data-breach-roundup-june-12-18-2026/